Lauren Mastrocola, Principal Accounting Officer at Praxis Precision Medicines, Inc. (PRAX), sold 27,200 shares at $192.71 ($5.2M) on 2025-11-20, disclosed to the SEC on 2025-11-21.
Open-market sale of $5.2M PRAX by Principal Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $191.96 | 11,455 | $2.2M | 42.1% |
| 2 | $191.96 | 11,455 | $2.2M | 42.1% |
| 3 | $192.71 | 2,145 | $413K | 7.9% |
| 4 | $192.71 | 2,145 | $413K | 7.9% |
| Total | $192.08 avg | 27,200 | $5.2M | 100% |
| Filing → |